Does TOFERSEN Cause Pulmonary embolism? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Pulmonary embolism have been filed in association with TOFERSEN (QALSODY). This represents 1.9% of all adverse event reports for TOFERSEN.
7
Reports of Pulmonary embolism with TOFERSEN
1.9%
of all TOFERSEN reports
1
Deaths
6
Hospitalizations
How Dangerous Is Pulmonary embolism From TOFERSEN?
Of the 7 reports, 1 (14.3%) resulted in death, 6 (85.7%) required hospitalization.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFERSEN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TOFERSEN Cause?
Procedural pain (42)
Amyotrophic lateral sclerosis (38)
Headache (37)
Post lumbar puncture syndrome (34)
Death (26)
Back pain (20)
Fatigue (17)
Fall (16)
Pain in extremity (16)
Pain (14)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which TOFERSEN Alternatives Have Lower Pulmonary embolism Risk?
TOFERSEN vs TOLNAFTATE
TOFERSEN vs TOLODODEKIN ALFA
TOFERSEN vs TOLTERODINE
TOFERSEN vs TOLVAPTAN
TOFERSEN vs TOPAMAX